Yes- not redoing anything beyond what they already are redoing(i.e. the redoing the 24 participants in the obesity study arm that they "forgot" to weigh).
However- I believe In the CC they mentioned they were going to do a ph 2a T2D "optimization" study and I got the sense that this was a new study they had not planned on prior to a 2b in T2D.
All of their planned studies on their GLP1 oral are shown on slide 32 of the cc presentation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.